Holm Mari, Morken Tora S, Fichorova Raina N, VanderVeen Deborah K, Allred Elizabeth N, Dammann Olaf, Leviton Alan
Department of Clinical and Molecular Medicine, Faculty of Medicine, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Pediatrics, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.
Invest Ophthalmol Vis Sci. 2017 Dec 1;58(14):6419-6428. doi: 10.1167/iovs.17-21931.
To assess the association between systemic levels of inflammation-associated proteins and severe retinopathy of prematurity (ROP) in extremely preterm infants.
We collected whole blood on filter paper on postnatal days 1, 7, 14, 21, and 28 from 1205 infants born before the 28th week of gestation, and measured the concentrations of 27 inflammation-associated, angiogenic, and neurotrophic proteins. We calculated odds ratios with 95% confidence intervals for the association between top quartile concentrations of each protein and prethreshold ROP.
During the first three weeks after birth, high concentrations of VEGF-R1, myeloperoxidase (MPO), IL-8, intercellular adhesion molecule (ICAM)-1, matrix metalloproteinase 9, erythropoietin, TNF-α, and basic fibroblast growth factor were associated with an increased risk for prethreshold ROP. On day 28, high levels of serum amyloid A, MPO, IL-6, TNF-α, TNF-R1/-R2, IL-8, and ICAM-1 were associated with an increased risk. Top quartile concentrations of the proinflammatory cytokines TNF-α and IL-6 were associated with increased risks of ROP when levels of neuroprotective proteins and growth factors, including BDNF, insulin-like growth factor 1, IGFBP-1, VEGFR-1 and -2, ANG-1 and PlGF, were not in the top quartile. In contrast, high concentrations of NT-4 and BDNF appeared protective only in infants without elevated inflammatory mediators.
Systemic inflammation during the first postnatal month was associated with an increased risk of prethreshold ROP. Elevated concentrations of growth factors, angiogenic proteins, and neurotrophins appeared to modulate this risk, and were capable of reducing the risk even in the absence of systemic inflammation.
评估极低出生体重儿全身炎症相关蛋白水平与重度早产儿视网膜病变(ROP)之间的关联。
我们收集了1205例孕28周前出生婴儿在出生后第1、7、14、21和28天的滤纸干血斑,检测了27种炎症相关、血管生成和神经营养蛋白的浓度。我们计算了每种蛋白最高四分位数浓度与阈值前ROP之间关联的比值比及95%置信区间。
出生后的前三周,血管内皮生长因子受体1(VEGF-R1)、髓过氧化物酶(MPO)、白细胞介素-8(IL-8)、细胞间黏附分子(ICAM)-1、基质金属蛋白酶9、促红细胞生成素、肿瘤坏死因子-α(TNF-α)和碱性成纤维细胞生长因子的高浓度与阈值前ROP风险增加相关。在第28天,血清淀粉样蛋白A、MPO、IL-6、TNF-α、肿瘤坏死因子受体1/2(TNF-R1/-R2)、IL-8和ICAM-1的高水平与风险增加相关。当神经营养蛋白和生长因子(包括脑源性神经营养因子(BDNF)、胰岛素样生长因子1、胰岛素样生长因子结合蛋白-1、血管内皮生长因子受体1和2、血管生成素-1和胎盘生长因子(PlGF))水平不在最高四分位数时,促炎细胞因子TNF-α和IL-6的最高四分位数浓度与ROP风险增加相关。相反,高浓度的神经营养因子-4(NT-4)和BDNF仅在炎症介质未升高的婴儿中表现出保护作用。
出生后第一个月的全身炎症与阈值前ROP风险增加相关。生长因子、血管生成蛋白和神经营养因子浓度升高似乎可调节这种风险,即使在无全身炎症的情况下也能降低风险。